Insider Trading & Ownership - Pontifax (China) IV L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Pontifax (China) IV L.P.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2021-05-13
Purchase		2021-05-17
07:03 am		Eloxx Pharmaceuticals Inc.ELOXPontifax Management 4 G.P. (2015) Ltd.
Pontifax (China) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax IV GP L.P.
10% Owner		5,925,925$1.35$7,999,999616,592
(Indirect)		View
2020-11-17
Purchase		2020-11-19
4:40 pm		Keros Therapeutics Inc.KROSNussbaum Ran
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner		60,000$50$3,000,000155,262
(Indirect)		View
2020-11-17
Purchase		2020-11-19
4:39 pm		Keros Therapeutics Inc.KROSKariv Tomer
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner		60,000$50$3,000,000155,262
(Indirect)		View
2020-11-17
Purchase		2020-11-19
4:38 pm		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		60,000$50$3,000,000155,262
(Indirect)		View
2020-04-13
Purchase		2020-04-13
5:18 pm		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		437,499$16$6,999,984149,262
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2022-11-29
Exercise		2022-11-30
4:42 pm		N/A
N/A		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		7,176$0.00011,226,412
(Indirect)		View
2022-11-29
Exercise		2022-11-30
4:42 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		7,176$01,226,412
(Indirect)		View

Ownership(A)		2022-11-30
4:37 pm		N/A
2023-10-07		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		0$07,176
(Indirect)		View
2020-05-20
Option Award		2020-05-22
4:10 pm		N/A
2030-05-20		Eloxx Pharmaceuticals Inc.ELOXPontifax Management 4 G.P. (2015) Ltd.
Pontifax IV GP L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner		40,000$040,000
(Indirect)		View
2020-04-13
Conversion		2020-04-13
5:18 pm		N/A
N/A		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		3,545,100$0149,262
(Indirect)		View

Ownership		2020-04-07
8:14 pm		N/A
N/A		Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner		0$04,297,008
(Indirect)		View
(A) Indicate amendment filing.